BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16607645)

  • 21. SMAD2 overexpression rescues the TGF-β3 null mutant mice cleft palate by increased apoptosis.
    AlMegbel AM; Shuler CF
    Differentiation; 2020; 111():60-69. PubMed ID: 31677482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of N'-nitrosonornicotine (NNN) on murine palatal fusion in vitro.
    Saito T; Cui XM; Yamamoto T; Shiomi N; Bringas P; Shuler CF
    Toxicology; 2005 Feb; 207(3):475-85. PubMed ID: 15664274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of extracellular signal-regulated kinase by TGF-beta1 via TbetaRII and Smad7 dependent mechanisms in human bronchial epithelial BEP2D cells.
    Huo YY; Hu YC; He XR; Wang Y; Song BQ; Zhou PK; Zhu MX; Li G; Wu DC
    Cell Biol Toxicol; 2007 Mar; 23(2):113-28. PubMed ID: 17096210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transforming growth factor beta (TGFbeta) signalling in palatal growth, apoptosis and epithelial mesenchymal transformation (EMT).
    Nawshad A; LaGamba D; Hay ED
    Arch Oral Biol; 2004 Sep; 49(9):675-89. PubMed ID: 15275855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling.
    Brown KA; Pietenpol JA; Moses HL
    J Cell Biochem; 2007 May; 101(1):9-33. PubMed ID: 17340614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of TGF-beta 3 (but not TGF-beta 1 or TGF-beta 2) activity prevents normal mouse embryonic palate fusion.
    Brunet CL; Sharpe PM; Ferguson MW
    Int J Dev Biol; 1995 Apr; 39(2):345-55. PubMed ID: 7669547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occurrence of cleft-palate and alteration of Tgf-β(3) expression and the mechanisms leading to palatal fusion in mice following dietary folic-acid deficiency.
    Maldonado E; Murillo J; Barrio C; del Río A; Pérez-Miguelsanz J; López-Gordillo Y; Partearroyo T; Paradas I; Maestro C; Martínez-Sanz E; Varela-Moreiras G; Martínez-Álvarez C
    Cells Tissues Organs; 2011; 194(5):406-20. PubMed ID: 21293104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenesis of cleft palate in TGF-beta3 knockout mice.
    Taya Y; O'Kane S; Ferguson MW
    Development; 1999 Sep; 126(17):3869-79. PubMed ID: 10433915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clusterin, a novel modulator of TGF-beta signaling, is involved in Smad2/3 stability.
    Lee KB; Jeon JH; Choi I; Kwon OY; Yu K; You KH
    Biochem Biophys Res Commun; 2008 Feb; 366(4):905-9. PubMed ID: 18082619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transforming growth factor-beta3 promotes mesenchymal cell proliferation and angiogenesis mediated by the enhancement of cyclin D1, Flk-1, and CD31 gene expression during CL/Fr mouse lip fusion.
    Muraoka N; Shum L; Fukumoto S; Nomura T; Ohishi M; Nonaka K
    Birth Defects Res A Clin Mol Teratol; 2005 Dec; 73(12):956-65. PubMed ID: 16323168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tgf-beta3-induced palatal fusion is mediated by Alk-5/Smad pathway.
    Dudas M; Nagy A; Laping NJ; Moustakas A; Kaartinen V
    Dev Biol; 2004 Feb; 266(1):96-108. PubMed ID: 14729481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cooperation between GATA4 and TGF-beta signaling regulates intestinal epithelial gene expression.
    Belaguli NS; Zhang M; Rigi M; Aftab M; Berger DH
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1520-33. PubMed ID: 17290010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multi-layered hypertrophied MEE formation by microtubule disruption via GEF-H1/RhoA/ROCK signaling pathway.
    Kitase Y; Shuler CF
    Dev Dyn; 2012 Jul; 241(7):1169-82. PubMed ID: 22565548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular and morphologic changes during the epithelial-mesenchymal transformation of palatal shelf medial edge epithelium in vitro.
    Shuler CF; Guo Y; Majumder A; Luo RY
    Int J Dev Biol; 1991 Dec; 35(4):463-72. PubMed ID: 1801871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of activated Smad2 in transforming growth factor-beta signaling is an unfavorable prognostic factor in patients with esophageal squamous cell carcinoma.
    Fukuchi M; Nakajima M; Miyazaki T; Masuda N; Osawa H; Manda R; Tsukada K; Kato H; Kuwano H
    J Surg Oncol; 2006 Jul; 94(1):51-6. PubMed ID: 16788944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maternal Smad3 deficiency compromises decidualization in mice.
    Zhao KQ; Lin HY; Zhu C; Yang X; Wang H
    J Cell Biochem; 2012 Oct; 113(10):3266-75. PubMed ID: 22644778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromatin immunoprecipitation on microarray analysis of Smad2/3 binding sites reveals roles of ETS1 and TFAP2A in transforming growth factor beta signaling.
    Koinuma D; Tsutsumi S; Kamimura N; Taniguchi H; Miyazawa K; Sunamura M; Imamura T; Miyazono K; Aburatani H
    Mol Cell Biol; 2009 Jan; 29(1):172-86. PubMed ID: 18955504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitumor activity of TGF-beta inhibitor is dependent on the microenvironment.
    Medicherla S; Li L; Ma JY; Kapoun AM; Gaspar NJ; Liu YW; Mangadu R; O'Young G; Protter AA; Schreiner GF; Wong DH; Higgins LS
    Anticancer Res; 2007; 27(6B):4149-57. PubMed ID: 18229422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transforming growth factor-beta1 and activin A generate antiproliferative signaling in thyroid cancer cells.
    Matsuo SE; Leoni SG; Colquhoun A; Kimura ET
    J Endocrinol; 2006 Jul; 190(1):141-50. PubMed ID: 16837618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of TGF-beta/Smad signaling pathway on lung myofibroblast differentiation.
    Gu L; Zhu YJ; Yang X; Guo ZJ; Xu WB; Tian XL
    Acta Pharmacol Sin; 2007 Mar; 28(3):382-91. PubMed ID: 17303001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.